Dublin, June 23, 2022 (GLOBE NEWSWIRE) — The ‘Biocompatibility Testing: What You Need To Know’ course has been added to from ResearchAndMarkets.com offer.
The objective of the seminar is to teach participants how to use current ISO 10993-1 and FDA standards to establish a biosafety assessment plan, including how to document and implement their plan.
Attendees will not only learn how to assess their device for biohazards, but also understand when testing is not necessary. We will also see how to properly document these results and complete a biological evaluation report
Why you should participate:
All medical devices that have direct or indirect contact with the human body require an assessment of the biocompatibility of the materials used to manufacture the device, with the testing schedule depending on the nature and duration of bodily contact. National and international regulatory agencies emphasize the use of risk-based approaches to assess biocompatibility.
February 18, 2021 (9:00 a.m. to 3:00 p.m. PST)
- Risk-Based Approach for Biocompatibility Assessment Strategy –
- Overview of current ISO 10993-1 and collateral standards Guidelines, costs and turnaround times for biocompatibility testing.
- Chemical characterization, leachables and extractables (L&E) testing and toxicological assessments.
- Alternative tests to time-consuming and expensive animal testing.
For more information on this training visit https://www.researchandmarkets.com/r/5only